期刊文献+

射频消融术在局部进展期胰腺癌中的临床应用 被引量:3

Analysis of Radiofrequency Ablation in the Treatment of Locally-Advanced Pancreatic Carcinoma
原文传递
导出
摘要 [目的]探讨射频消融术治疗局部进展期胰腺癌的临床疗效。[方法]本院收治的123例局部进展期胰腺癌患者,依据其姑息性手术中是否行射频消融术分为射频组和对照组,比较两组患者治疗及预后情况。[结果]123例患者均顺利完成手术,无围手术期死亡患者。射频组患者术后并发症发生率为21.7%(10/46),胰瘘发生率为6.5%(3/46),与对照组10.38%(8/77),1.3%(1/77)相比较差异均无显著性(P〉0.05)。射频组患者的半年、1年、2年生存率分为82.6%(38/46)、43.5%(20/46)、8.7%(4/46),平均生存时间为(13.5±0.8)个月;明显高于对照组55.8%(43/77)、27.27%(21/77)、0%和(9.1±0.3)个月,且差异均有显著性(P〈0.05)。[结论]射频消融术用于治疗局部进展期胰腺癌安全有效,其为胰腺癌患者的综合治疗提供了一种新的方法。 [Objective]To analysis of radiofrequency ablation in the treatment of locally-advanced pancreatic carcinoma. [Methods]We retrospectively analyzed the clinical data of 123 patients with locally-advanced pancreatic carcinoma. All the patients were divided into a radiofrequency group and a control group according to the radiofre quency ablation surgery. And then the perioperative and prognosis data of the two groups were analyzed and compared. [Results]In our research, all patients were successfully completed surgery and there were no cases of perio- perative death. The incidence of postoperative complications of radiofrequency group was 21.7% (control group rate 10.38 % ) and the incidence of pancreatic fistula was 6.5 % (control group rate 1.3%). There were no statistical differences between the two groups. The 6 months, 1 year and 2 years survival rates of radiofrequency group and control group were 82.4%, 43.5%, 7.6% and 55.8%, 28%, 0%, the average survival time were 13.5±0.8 months and 9.1±0.3 months. The prognosis of radiofrequency group was significantly better than that of the control group ( P〈0.05). [Conclusion]Radiofrequency ablation surgery is safe and effective in the treatment of local ly-advanced pancreatic carcinoma.
出处 《医学临床研究》 CAS 2017年第3期438-440,共3页 Journal of Clinical Research
关键词 导管消融术 胰腺肿瘤/外科学 手术后并发症 预后 Catheter Ablation Pancreatic Neoplasms/SU Postoperative Complications Prognosis
  • 相关文献

参考文献4

二级参考文献26

  • 1黄建钊,吴刚,杨俊涛,刘宏鸣,顾红光.射频消融治疗9例晚期胰腺癌[J].重庆医学,2005,34(12):1851-1852. 被引量:11
  • 2吕明德,匡铭,梁力建,谢晓燕,彭宝岗,刘广健,黎东明,赖佳明,李绍强.手术切除和经皮热消融治疗早期肝癌的随机对照临床研究[J].中华医学杂志,2006,86(12):801-805. 被引量:102
  • 3Wu Y, Tang Z, Fang II. et al. lliigh operative risk of cool-rip radiolrcquency ablation for unreseciable pancreatic head cancer. J Surg Oncol,2oo6 .94 :392-395.
  • 4Wah 'I'M, Arelano RS, Sahamacehia I)i\, PI al. image-guided percutaneous radiofrcqucncy ablation and incidence of post-radiolrequcncy ablation syndrome: prospective survey. Hadiology , 2005,237:1097-1102.
  • 5Frezza EE. Lapamscopic radiofrequeucy ablation of solitary hepatic-gaslrinoma metastases. Dig Dis Sci ,2004 ,49 :224-227.
  • 6Elias D, Balon 0, Sideris L, el ul. Npcrolizing pancreatitis after radiolrcquency destruction of pancreatic rumors. Eur J Surg Oneol , 2004,30 :85-87.
  • 7Spiliotis .ID, Datsis AC, Michalopoulos NV, cr al. Hadiofrr-quencj ablation combined with palliativr- surgery may prolong survival of patients wil h advanced cancer of the pancreas. langenbC'('ks Arch Surg,2oo7 ,392 :55-60.
  • 8Valentini V, Calvo F, EReni M.PI "I. lntm-opcrarive radiotherapy (IORT) in pancreatic cancerjoint analysis ofthe ISIOHT-Europe experience. Radiothcr Oncol,2oo9 ,91 :54-59 .
  • 9Kelleher FC.Hedgehog signaling and therapeutics in pancreatic cancer[J].Carcinogenesis,2011,32(4):445-451.
  • 10Kim HS,Yi SY,Jun H J,et al.Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer[J].Anticancer Drugs,2010,21(1):107-112.

共引文献57

同被引文献25

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部